Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 8 of 8 for “"ETOPOSIDE/VP-16"”.
-
Role of Cytochrome P450 Enzymes in Acute Myeloid Leukemia Bone Marrow Microenvironment
… drugs cytarabine (ara-C), daunorubicin and etoposide (VP-16), induce CYP3A4 and CDA levels in MSCs as well as increase stromal protective effect. Understanding how CYPs levels vary in AML BM during treatment provides a basis for combining a stromal CYP3A4 inhibitor with chemotherapy to …
-
Chemotherapy disrupts bone marrow stromal cell function
… the effects of the chemotherapeutic agent etoposide (VP-16) on bone marrow stromal cell function. We have previously demonstrated that stromal cells chronically exposed to VP-16 display diminished extra-cellular levels of SDF-1 resulting in disrupted support of pro-B cell chemotaxis. We …
-
Effects of high -dose chemotherapy on the bone marrow microenvironment
… vitro exposure to the topoisomerase II inhibitor etoposide (VP-16). VP-16-induced VCAM-1 down-regulation is associated with an impairment of stromal cell layers to support early lymphoid and myeloid cell proliferation. More recently, we evaluated stromal cell SDF-1 protein production following …
-
Enhanced Etoposide Solubility and Anticancer Activity using Complexation and Nanotechnology
Etoposide is a first line treatment for different cancer types that can be used either alone or in combination with other therapeutic agents. However, systemic toxicity, variable oral bioavailability, and high drug resistance are the three main drawbacks which hamper etoposide activity. The central …
-
Chemotherapy-Induced Damage of the Bone Marrow Microenvironment
… we investigated the effects of melphalan and Etoposide (VP-16) treatment on osteoblasts. Previous studies from our lab had shown that chemotherapy treatment increased the amount of active TGF-beta secreted from BMSC, leading to decreases in the ability to support pro-B cells. Here we describe …
-
Development of Closomer And MIBG based Nanoformulation: Application to HIV Prevention and Neuroblastoma Therapy
… (MIBG) based nanoformulation of etoposide (VP-16) intended for the treatment of neuroblastoma. This work is presented in 6 chapters as described below, and partially in 3 peer-reviewed papers (see appendix). Part #1 and #2 are summarized in Chapters 4-5 and 6, respectively. In …
-
In vitro Studies of Improvement in Treatment Efficiency of Photodynamic Therapy of Cancers through Near-Infrared/Bioluminescent Activation
… effect) values of 576 ± 13, 478 ± 18 and 360 ± 16 J cm-2 for 10 μM MPPa, which were approximately 3-5 times lower than the published 2-γ LD50 of Visudyne® and 20-30 times lower than that of Photofrin®. These results indicate that MPPa may serve as a photosensitizer for both 1- and 2-γ activated …
-
Μελέτη του ρόλου του NF-κB στην απόπτωση κυττάρων που εκτίθενται σε παράγοντες οξειδωτικού στρες και σε κυτταροκίνες
… addressed the role of NF-κB signaling in H₂O₂ or VP-16 treatment human lung tumor epithelial cells A549. To this end we genetically manipulated the NF-κB signaling pathways either using a super repressor of NF-κB, IκBαSR, or by knocking down its activating IKK kinases, IKKα and IKKβ. First, we …